Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/144621
New antimicrobial approaches to gram positive respiratory infections
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Nowadays, we face growing resistance among gram-positive and gram-negative pathogens that cause respiratory infection in the hospital and in the community. The spread of penicillin- and macrolide-resistant pneumococci, Community-acquired methicillin-resistant staphylococcus aureus (Ca-MRSA), the emergence of glycopeptide-resistant staphylococci underline the need for underline the need for therapeutic alternatives. A number of new therapeutic agents, with activity against the above Gram (+) respiratory pathogens, as ceftaroline, ceftopibrole, telavancin, tedizolid have become available, either in clinical trials or have been approved for clinical use. Especially, the development of new oral antibiotics, as nemonaxacin, omadacyclin, cethromycin and solithromycin will give a solution to the lack of oral drugs for outpatient treatment. In the future the clinician needs to optimize the use of old and new antibiotics to treat gram (+) respiratory serious infections.
Subject (English)
Citation
Citation
LIAPIKOU, Adamantia, et al. New antimicrobial approaches to gram positive respiratory infections. Pulmonary Pharmacology and Therapeutics. 2014. Vol. 32, num. 13-143. ISSN 1094-5539. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/144621